Sign In
Buy PCRX
$26.41
-0.560 (-2.08%)
At Close: Jul 31, 2026
Analysts Have Conflicting Sentiments on These Healthcare Companies: Horizon Therapeutics (HZNP) and Madrigal Pharmaceuticals (MDGL)
01:36pm, Tuesday, 14'th Apr 2020
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Horizon Therapeutics (HZNP) and Madrigal Pharmaceuticals
Companies in the
Healthcare sector have received a lot of coverage today as analysts
weigh in on Horizon Therapeutics (
HZNP
–
Research Report
) and Madrigal Pharmaceuticals (
MDGL
–
Research Repo
Analysts Are Bullish on These Healthcare Stocks: Sientra (SIEN), Pacira Pharmaceuticals (PCRX)
11:43am, Tuesday, 14'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Sientra (SIEN) and Pacira Pharmaceuticals (PCRX) with
Analysts Are Bullish on These Healthcare Stocks: Sientra (SIEN), Pacira Pharmaceuticals (PCRX)
11:43am, Tuesday, 14'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Sientra (SIEN
Amarin (AMRN) Receives a Hold from Stifel Nicolaus
02:22am, Tuesday, 14'th Apr 2020
In a report released yesterday, Derek Archila from Stifel Nicolaus reiterated a Hold rating on Amarin (AMRN). The company's shares closed last Monday at
Amarin (AMRN) Receives a Hold from Stifel Nicolaus
02:22am, Tuesday, 14'th Apr 2020
In a report released yesterday, Derek Archila from Stifel Nicolaus reiterated a Hold rating on Amarin (AMRN – Research Report).
Perrigo Company (PRGO) Receives a Buy from RBC Capital
02:45am, Monday, 13'th Apr 2020
RBC Capital analyst Randall Stanicky maintained a Buy rating on Perrigo Company (PRGO) on April 8 and set a price target of $58.00. The company's shares
RBC Capital Remains a Hold on AbbVie (ABBV)
02:45am, Monday, 13'th Apr 2020
In a report issued on April 8, Randall Stanicky from RBC Capital maintained a Hold rating on AbbVie (ABBV), with a price target of $79.00. The company's
RBC Capital Remains a Hold on AbbVie (ABBV)
02:45am, Monday, 13'th Apr 2020
In a report issued on April 8,
Randall Stanicky
from RBC Capital maintained a
Hold
rating on AbbVie (
ABBV
–
Research Report
), with a price target of
$79.00
. The company’s shares closed last Thu
Geode Capital Management LLC Acquires 20,203 Shares of Pacira Biosciences Inc (NASDAQ:PCRX)
09:20am, Sunday, 12'th Apr 2020
Geode Capital Management LLC grew its holdings in shares of Pacira Biosciences Inc (NASDAQ:PCRX) by 3.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutio
Genefit (GNFTF) Gets a Hold Rating from Stifel Nicolaus
05:40am, Sunday, 12'th Apr 2020
Stifel Nicolaus analyst Derek Archila reiterated a Hold rating on Genefit (GNFTF – Research Report) on April 9 and set
StartUPDATES: New developments from healthcare startups
05:50pm, Friday, 10'th Apr 2020
A roundup of new developments spotlighting startups this week including HealCo, PatientWing, as well as new research from Rock Health.
Should You Be Concerned About Pacira BioSciences, Inc.’s (NASDAQ:PCRX) Historical Volatility?
06:42pm, Wednesday, 08'th Apr 2020
If you own shares in Pacira BioSciences, Inc. (NASDAQ:PCRX) then it's worth thinking about how it contributes to the...
Weekly Analysts' Ratings Changes for Pacira Biosciences (PCRX)
09:06am, Wednesday, 08'th Apr 2020
A number of firms have modified their ratings and price targets on shares of Pacira Biosciences (NASDAQ: PCRX) recently: 4/7/2020 – Pacira Biosciences is now covered by analysts at Northland Securit
